MVA ME-TRAP
Sponsors
London School of Hygiene and Tropical Medicine, University of Oxford, University Hospital Tuebingen
Conditions
MalariaMalaria, FalciparumPlasmodium Falciparum Malaria
Phase 1
Malaria Infection Diagnosed by Polymerase Chain Reaction (PCR) as a Means of Evaluating Pre-erythrocytic Candidate Malaria Vaccines
CompletedNCT00121823
Start: 2004-06-30End: 2004-12-31Target: 120Updated: 2017-01-12
Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen
CompletedNCT00408668
Start: 2005-08-31End: 2006-02-28Target: 30Updated: 2006-12-07
A Study to Assess the Effectiveness of a New Malaria Vaccine Candidate by Infecting Vaccinated Volunteers With Malaria Parasites
CompletedNCT00890760
Start: 2009-03-31End: 2011-02-28Updated: 2012-11-29
A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S
CompletedNCT01883609
Start: 2013-09-30End: 2014-08-31Updated: 2014-10-01
A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAP
CompletedNCT02905019
Start: 2016-08-31End: 2017-12-21Updated: 2018-06-13
A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration
CompletedNCT03084289
Start: 2017-03-28End: 2020-07-06Updated: 2020-10-09
Comparing Safety and Protective Efficacy of Vaccine Candidate PfSPZ-CVac and MVA ME-TRAP/ ChAd63 ME-TRAP in Adults
Not yet recruitingNCT05441410
Start: 2025-06-01End: 2026-06-30Target: 30Updated: 2024-12-06